Notice of the special general meeting
Filed with HKEX · Stock code 512 · · 2 pages · English
Summary by 6ix AI
This filing is a notice for a special general meeting of Grand Pharmaceutical Group Limited, scheduled to discuss key resolutions regarding the company's auditor appointment. The extraordinary resolution proposes to terminate the current auditor, while the ordinary resolution suggests appointing a new auditor. Shareholders are informed about proxy voting rights and arrangements in case of bad weather on the meeting day.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Grand Pharmaceutical Group Limited on 6ix
Earlier from Grand Pharmaceutical
- Voluntary announcement: the international multi-center phase III clinical trial for the treatment of pterygium of the group's global innovative ophthalmic drug CBT-001 has reached its primary clinical endpoint
- Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
- Supplemental announcement in relation to proposed change of auditors
- Proposed change of auditors
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
Later from Grand Pharmaceutical
- Notice of availability to Non-registered Shareholders and Reply Form
- Notice of availability to Registered Shareholders and Reply Form
- Proxy form for the special general meeting to be held on Wednesday, 25 November 2026 or any adjournment thereof
Follow Grand Pharmaceutical into a list and get an email when it puts out news.
Follow Grand Pharmaceutical